Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Luca Romano

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Biomedicines|October 23, 2021
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic ReviewMario Damiano Toro, Lucia Gozzo, Luciano Tracia, et al.
International Journal of Environmental Research and Public Health|May 6, 2020
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental SettingsLuca Fiorillo, Gabriele Cervino, Marco Matarese, et al.
Nutrients|August 10, 2024
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of ActionJustyna Godos, Giovanni Luca Romano, Samuele Laudani, et al.
Frontiers in Pharmacology|April 2, 2024
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiotaJustyna Godos, Giovanni Luca Romano, Lucia Gozzo, et al.
Journal of Clinical Medicine|July 29, 2025
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with VenetoclaxFanny Erika Palumbo, Andrea Duminuco, Laura Longo, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved?Samuele Laudani, Justyna Godos, Giovanni Luca Romano, et al.
Journal of Clinical Medicine|August 14, 2025
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational StudyErmelinda Longo, Fanny Erika Palumbo, Andrea Duminuco, et al.
European Journal of Pharmacology|February 1, 2025
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicityFederica Conti, Francesca Lazzara, Kyriaki Thermos, et al.
Hematology Reports|October 28, 2025
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance DatabasePier Paolo Olimpieri, Fanny Erika Palumbo, Gaetano Giuffrida, et al.
International Journal of Pharmaceutics|September 17, 2022
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy modelAlessia Romeo, Angela Bonaccorso, Claudia Carbone, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Biomedicines|October 23, 2021
New Therapeutic Perspectives in the Treatment of Uveal Melanoma: A Systematic ReviewMario Damiano Toro, Lucia Gozzo, Luciano Tracia, et al.
International Journal of Environmental Research and Public Health|May 6, 2020
COVID-19 Surface Persistence: A Recent Data Summary and Its Importance for Medical and Dental SettingsLuca Fiorillo, Gabriele Cervino, Marco Matarese, et al.
Nutrients|August 10, 2024
Flavan-3-ols and Vascular Health: Clinical Evidence and Mechanisms of ActionJustyna Godos, Giovanni Luca Romano, Samuele Laudani, et al.
Frontiers in Pharmacology|April 2, 2024
Resveratrol and vascular health: evidence from clinical studies and mechanisms of actions related to its metabolites produced by gut microbiotaJustyna Godos, Giovanni Luca Romano, Lucia Gozzo, et al.
Journal of Clinical Medicine|July 29, 2025
Length of Washout Period After Remission Does Not Influence Relapse Risk in Patients with Acute Myeloid Leukemia Treated with Hypomethylating Agents Combined with VenetoclaxFanny Erika Palumbo, Andrea Duminuco, Laura Longo, et al.
Pharmaceuticals (Basel, Switzerland)|February 24, 2024
Isoflavones Effects on Vascular and Endothelial Outcomes: How Is the Gut Microbiota Involved?Samuele Laudani, Justyna Godos, Giovanni Luca Romano, et al.
Journal of Clinical Medicine|August 14, 2025
Does the Timing of Response Impact the Outcome of Relapsed/Refractory Acute Myeloid Leukemia Treated with Venetoclax in Combination with Hypomethylating Agents? A Proof of Concept from a Monocentric Observational StudyErmelinda Longo, Fanny Erika Palumbo, Andrea Duminuco, et al.
European Journal of Pharmacology|February 1, 2025
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicityFederica Conti, Francesca Lazzara, Kyriaki Thermos, et al.
Hematology Reports|October 28, 2025
Vitamin K Antagonists (VKAs) and Novel Oral Anticoagulants (NOACs) Safety Comparison Based on Data from EudraVigilance DatabasePier Paolo Olimpieri, Fanny Erika Palumbo, Gaetano Giuffrida, et al.
International Journal of Pharmaceutics|September 17, 2022
Melatonin loaded hybrid nanomedicine: DoE approach, optimization and in vitro study on diabetic retinopathy modelAlessia Romeo, Angela Bonaccorso, Claudia Carbone, et al.
Pageof 5